US Patent 9585921 Compositions and methods
Patent 9585921 was granted and assigned to Seres Therapeutics on March, 2017 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9585921 Compositions and methods
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.